

Clinical Trials Asia 2023 is the APAC region’s premier event for clinical trials and clinical research leaders to gather and share insights on early and late phase trial protocol design, participant recruitment, decentralised clinical trials,and best practices for efficiently managing increasingly complex clinical trials.
With countries like Singapore, South Korea and Australia more attractive than ever for international drugmakers to run clinical trials there, we’ll bring thought leaders and biopharmaceutical companies together to discuss partnerships, outsourcing, regulation, patient diversity and engagement, digital strategy, medical imaging and more.
Clinical Trials Asia 2023 features market researched and tested content carefully developed to help leading organisations decide the partnerships, technology and services needed to run best in class clinical trials and enhance their drug discovery and translation.
Clinical Trials Asia 2023 is the APAC region’s premier event for clinical trials and clinical research leaders to gather and share insights on early and late phase trial protocol design, participant recruitment, decentralised clinical trials,and best practices for efficiently managing increasingly complex clinical trials.
With countries like Singapore, South Korea and Australia more attractive than ever for international drugmakers to run clinical trials there, we’ll bring thought leaders and biopharmaceutical companies together to discuss partnerships, outsourcing, regulation, patient diversity and engagement, digital strategy, medical imaging and more.
Clinical Trials Asia 2023 features market researched and tested content carefully developed to help leading organisations decide the partnerships, technology and services needed to run best in class clinical trials and enhance their drug discovery and translation. VPs and Heads of Supply Chain, Logistics and Cold Chain Management from vaccine manufacturers, biopharma and biologics companies from APAC and the rest of the world will meet with each other as well as other technology and solution providers and global experts to evaluate the latest strategies, technologies and solutions in building a technologically enhanced high-speed and resilient vein-to-vein supply chain fit-for-purpose for the boom in temperature sensitive biologics moving through Asia’s clinical trials and markets.
Regulations and Outlook of APAC’s Global Clinical Trial Hub
Patient Recruitment & Trial Financingnt
CGT Trials Operations Optimisation
Early & Late Phase Trials Planning
Clinical Trials Research Networks and Infrastructure
Decentralised and Multi-Centre Trials
Post-Authorisation and Market Access
Clinical Procurement and Raw Materials Supply Chain
Biopharma/ Big Pharma/ Academic (Asia)
Biopharma/ Big Pharma/ Academic (Outside of Asia)
SOLUTION PROVIDER
- BUY3GET 10% OFF
- 2- Day Conference Access
- Early Bird ends 1st March 2023 (U.P 4995)